Nick is a Reader in Health Economics at the School of Health and Related Research (ScHARR) at the University of Sheffield. He joined ScHARR in June 2008. Before this he graduated with a degree in economics from the University of Nottingham in 2003 and an MSc in Health Economics from the University of York in 2004. Nick has experience in both public and private sectors having previously worked as an Analyst at NERA Economic Consulting, a Health Economics Fellow at Queen Mary, University of London (QMUL), and a Health Economist at Roche Products Ltd. Much of Nick’s work focuses on the incorporation of survival analysis in economic evaluations – particularly the use of statistical methods for adjusting survival estimates in the presence of treatment switching in clinical trials. Nick works closely with the NICE Decision Support Unit (DSU) and has authored three DSU technical support documents (TSD) on survival analysis (TSD14), the use of treatment switching adjustment methods in the context of economic evaluation (TSD16), and partitioned survival modelling (TSD19). He has led the Evidence Review Group (ERG) on NICE Technology Appraisals, has contributed to NICE Public Health guidelines, and has conducted several economic evaluations alongside clinical trials. In 2009 Nick was awarded an NIHR Doctoral Research Fellowship on the topics of survival analysis, treatment switching and economic evaluation, which he completed in 2012. In 2016 Nick began an NIHR Post-Doctoral Fellowship, further studying treatment switching adjustment methods. In 2019 he will begin a 5-year Senior Research Fellowship funded by Yorkshire Cancer Research, concentrating on treatment switching adjustment and the use of real world datasets to estimate treatment effects. Nick teaches Economic Evaluation to MSc students. He is a member of the Health Economists Study Group, is a Fellow of the Higher Education Academy, has been an invited expert on the NICE Scientific Advice Programme and is a current member of NICE Technology Appraisal Committee B.